Optimized uptake time of 18F-THK5351 PET/CT in normal Thai brain

被引:0
|
作者
Thonglim, Pachara [1 ]
Chotipanich, Chanisa [2 ]
Buranasiri, Prathan [1 ]
机构
[1] King Mongkuts Inst Technol Ladkrabang, Fac Sci, Dept Phys, Bangkok 10520, Thailand
[2] Chulabhorn Hosp, Natl Cyclotron & PET Ctr, Div Nucl Med, Bangkok 10210, Thailand
来源
JOURNAL OF PHYSICS COMMUNICATIONS | 2019年 / 3卷 / 07期
关键词
F-18-THK5351; positron emission tomography-computed tomography (PET/CT); optimized uptake time; discrete time; continuous time; Alzheimer's disease (AD); ana75_2m.mat; NEUROFIBRILLARY TANGLES; ALZHEIMERS-DISEASE; IMAGING TRACER; TAU; ANNIHILATION; PATHOLOGY; PLAQUES;
D O I
10.1088/2399-6528/ab3428
中图分类号
O4 [物理学];
学科分类号
0702 ;
摘要
This study investigated F-18-THK5351 positron emission tomography-computed tomography (PET/CT) images to determine the optimized imaging time of radiopharmaceutical PET/CT in normal Thai population. Seventeen volunteers without any neurological or psychiatric illnesses, who showed no abnormalities upon neurological examination and the standardized uptake value ratio, were included. All subjects were diagnosed using F-18-THK5351 PET/CT and 3.0 Tesla magnetic resonance imaging (MRI). THK5351 PET/CT was operated on the co-registered MRI to draw a region of interest (ROI). A digital imaging and communications in a medical file were converted to a .img file. Next, the image file was rendered from discrete time to continuous time for plotting graphs. The ROI positions and rendered file were then used to plot a graph showing the relationship between the radiopharmaceutical uptake quantity and the interval time to determine the optimized uptake time of THK5351 PET/CT for the brains of normal Thai population, which was consequently 40-60 min.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The Optimized Time of 18F-THK5351 PET/CT in Normal Thai Population
    Thonglim, Pachara
    Sungkarat, Witaya
    Chotipanich, Chanisa
    Somphonsane, Ratchanok
    Phoemphoonthanyakit, Suwaphit
    Buranasiri, Prathan
    BIOPHOTONICS: PHOTONIC SOLUTIONS FOR BETTER HEALTH CARE VI, 2018, 10685
  • [2] 18F-THK5351 PET in corticobasal syndrome
    Kikuchi, A.
    Okamura, N.
    Hasegawa, T.
    Ezura, M.
    Baba, T.
    Sugeno, N.
    Yoshida, S.
    Kobayashi, J.
    Arai, H.
    Furumoto, S.
    Tashiro, M.
    Yanai, K.
    Kudo, Y.
    Takeda, A.
    Aoki, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 802 - 802
  • [3] The spatial accumulation patterns in normal elderly using 18F-THK5351 pet
    Yokoi, T.
    Watanabe, H.
    Aya, O.
    Kawabata, K.
    Imai, K.
    Hara, K.
    Masuda, M.
    Ohdake, R.
    Yamaguchi, H.
    Miyao, S. I.
    Katsuno, M.
    Okamura, N.
    Yanai, K.
    Sobue, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 960 - 960
  • [4] 18F-THK5351 PET in Patients with Clinically Diagnosed PSP
    Rominger, A.
    Brendel, M.
    Schonecker, S.
    Hoeglinger, G.
    Lindner, S.
    Danek, A.
    Levin, J.
    Bartenstein, P.
    Okamura, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S132 - S132
  • [5] Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
    Ryuichi Harada
    Shozo Furumoto
    Tetsuro Tago
    Furukawa Katsutoshi
    Aiko Ishiki
    Naoki Tomita
    Ren Iwata
    Manabu Tashiro
    Hiroyuki Arai
    Kazuhiko Yanai
    Yukitsuka Kudo
    Nobuyuki Okamura
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 2211 - 2218
  • [6] Prediction of prognosis for mild cognitive impairment by 18F-THK5351 PET
    Ishiki, A.
    Ueda, J.
    Tomita, N.
    Numasaki, M.
    Okinaga, S.
    Arai, H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2018, 66 : S92 - S92
  • [7] 18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury
    Takami, Yasukage
    Yamamoto, Yuka
    Norikane, Takashi
    Mitamura, Katsuya
    Hatakeyama, Tetsuhiro
    Nishiyama, Yoshihiro
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (11) : E491 - E492
  • [8] Feasibility of 18F-THK5351 PET quantitation using the Centiloid scale
    Yamao, Tensho
    Miwa, Kenta
    Matsuda, Hiroshi
    Akamatsu, Go
    Wagatsuma, Kei
    Takano, Harumasa
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [9] Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
    Kok Pin Ng
    Tharick A. Pascoal
    Sulantha Mathotaarachchi
    Joseph Therriault
    Min Su Kang
    Monica Shin
    Marie-Christine Guiot
    Qi Guo
    Ryuichi Harada
    Robert A. Comley
    Gassan Massarweh
    Jean-Paul Soucy
    Nobuyuki Okamura
    Serge Gauthier
    Pedro Rosa-Neto
    Alzheimer's Research & Therapy, 9
  • [10] Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351
    Harada, Ryuichi
    Furumoto, Shozo
    Tago, Tetsuro
    Katsutoshi, Furukawa
    Ishiki, Aiko
    Tomita, Naoki
    Iwata, Ren
    Tashiro, Manabu
    Arai, Hiroyuki
    Yanai, Kazuhiko
    Kudo, Yukitsuka
    Okamura, Nobuyuki
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (12) : 2211 - 2218